Editas Medicine (EDIT) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to -$165.6 million.
- Editas Medicine's Enterprise Value rose 3751.21% to -$165.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$165.6 million, marking a year-over-year increase of 3751.21%. This contributed to the annual value of -$269.9 million for FY2024, which is 1646.43% up from last year.
- Editas Medicine's Enterprise Value amounted to -$165.6 million in Q3 2025, which was up 3751.21% from -$178.5 million recorded in Q2 2025.
- Over the past 5 years, Editas Medicine's Enterprise Value peaked at -$165.6 million during Q3 2025, and registered a low of -$625.3 million during Q1 2021.
- In the last 5 years, Editas Medicine's Enterprise Value had a median value of -$344.3 million in 2022 and averaged -$373.5 million.
- In the last 5 years, Editas Medicine's Enterprise Value tumbled by 5068.52% in 2021 and then surged by 3751.21% in 2025.
- Quarter analysis of 5 years shows Editas Medicine's Enterprise Value stood at -$499.8 million in 2021, then soared by 31.12% to -$344.3 million in 2022, then increased by 6.15% to -$323.1 million in 2023, then rose by 16.46% to -$269.9 million in 2024, then soared by 38.63% to -$165.6 million in 2025.
- Its Enterprise Value was -$165.6 million in Q3 2025, compared to -$178.5 million in Q2 2025 and -$221.0 million in Q1 2025.